[HTML][HTML] ERCC3, a new ovarian cancer susceptibility gene?

A Stradella, J Del Valle, P Rofes… - … Journal of Cancer, 2020 - Elsevier
… to confirm ERCC3 as a cancer susceptibility gene for breast cancer and … risk of carriers
for BC and OC, among other tumours. Our data also indicate a putative modifier role of ERCC3

Re: ERCC3, a new ovarian cancer susceptibility gene?

J Soukupova, P Zemankova, P Nehasil… - … Journal of Cancer, 2021 - ejcancer.com
… only one ERCC3 mutation (0.11%; OR = 0,2; 95%CI 0,0–1,7). To further delineate the prevalence
of germline ERCC3 mutations in Czech cancer … data from cancer predisposition testing …

Response to letter entitled: Re: ERCC3 a new ovarian cancer susceptibility gene?

A Stradella, J Del Valle, J Brunet… - … Journal of Cancer, 2021 - ejcancer.com
… expect to find this gene mutated in high-risk families with a high cancer family history burden…
identified in another cancer risk gene. Hence, five out of 13 ERCC3 Spanish carriers were …

A unique subset of epithelial ovarian cancers with platinum sensitivity and PARP inhibitor resistance

R Ceccaldi, KW O'Connor, KW Mouw, AY Li… - Cancer research, 2015 - AACR
… Overall, our findings reveal a new mechanism of platinum sensitivity in EOC that, unlike
defective HR, may lead to a discordance in sensitivity to platinum and PARPi, with potential …

Genetic predisposition to breast and ovarian cancers: how many and which genes to test?

D Angeli, S Salvi, G Tedaldi - International journal of molecular sciences, 2020 - mdpi.com
… of many new genes involved in the predisposition to breast and/or ovarian cancer, with different
… identified as high penetrance genes for the risk of breast/ovarian cancers. Besides them, …

Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy.

M Dabholkar, J Vionnet… - The Journal of …, 1994 - Am Soc Clin Investig
… helicases encoded by ERCC2, ERCC3, and ERCC6 (2, 13). The present study examines
relative mRNA levels of expression of ERCC1 and XPAC in ovarian cancer tissues. We also …

Genetic markers for prediction of treatment outcomes in ovarian cancer

E Caiola, M Broggini, M Marabese - The Pharmacogenomics Journal, 2014 - nature.com
… In this paper, we review candidates for genetic markers of treatment outcomes in ovarian
cancer. Although an association between SNPs and response to chemotherapy has been …

… excision repair protein ERCC1 and tumour-infiltrating lymphocytes are potential biomarkers of neoadjuvant platinum resistance in high grade serous ovarian cancer

J Scurry, B van Zyl, D Gulliver, G Otton, K Jaaback… - Gynecologic …, 2018 - Elsevier
… High grade serous ovarian cancer is (HGSOC) treated by up front cytoreduction surgery …
In HGS ovarian cancer, HR deficiency as a result of BRCA mutations, results in increased …

Targeting DNA damage response pathway in ovarian clear cell carcinoma

OGW Wong, J Li, ANY Cheung - Frontiers in Oncology, 2021 - frontiersin.org
… XPB (ERCC3), key players in the NER pathway, tend to be higher in OCCC as compared to
other types of ovarian cancers (… a new paradigm for utilizing PI3K inhibitors in ovarian cancer

… group C single‐nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression‐free survival in advanced ovarian cancer

ND Fleming, H Agadjanian, H Nassanian, CW Miller… - Cancer, 2012 - Wiley Online Library
new cases of ovarian cancer diagnosed, leading to 14,000 deaths.1 Primary treatment for
newly diagnosed ovarian cancer is … NER pathway in both ovarian cancer risk and response to …